Patient info Search Menu

Travoprost 40 micrograms / ml eye drops solution – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
40 micrograms / ml
Contains active substance:
ATC code:

Patient leaflet - Travoprost 40 micrograms / ml eye drops solution

1 What Travoprost is and what it is used for

Travoprost Eye Drops, Solution contains travoprost, one of a group of medicines called prostaglandin analogues. It works by reducing the pressure in the eye. It may be used on its own or with other drops e.g. beta-blockers, which also reduce pressure.

Travoprost is used to reduce high pressure in the eye in adults, adolescents and children from 2 months old onward. This pressure can lead to an illness called glaucoma.

2 What you need to know before you use Travoprost

Do not use Travoprost

  • If you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6).

Ask your doctor for advice if this applies to you.

Warnings and precautions

  • Travoprost may increase the length, thickness, colour and/or number of your eyelashes. Changes in the eyelids including unusual hair growth or in the tissue around the eye have also been observed.
  • Travoprost may change the colour of your iris (the coloured part of your eye). This change may be permanent. A change in the colour of the skin around the eye may also occur.
  • If you have had cataract surgery, talk to your doctor before you use Travoprost.
  • If you have current or previous history of an eye inflammation (iritis and uveitis), talk to your doctor before you use Travoprost.
  • Travoprost may rarely cause

    breathlessness or wheezing or increase the symptoms of asthma. If you are concerned about changes in your breathing pattern when using this medicine, talk to your doctor as soon as possible.

  • Travoprost may be absorbed through the skin. If any of the medicinal product comes into contact with the skin, it should be washed off straight away. This is especially important in women who are pregnant or are attempting to become pregnant.
  • If you wear soft contact lenses, do not use the drops with your lenses in. After using the drops wait 15 minutes before putting your lenses back in.

Children and adolescents

Travoprost can be used in children from 2 months to <18 years at the same dose as for adults. Use of Travoprost is not recommended to those children under 2 months of age.

Other medicines and Travoprost

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy, breast-feeding and fertility Do not use Travoprost if you are pregnant. If you think that you may be pregnant, speak with your doctor right away. If you could become pregnant you must use adequate contraception whilst you use this medicine.

Do not use Travoprost if you are breast-feeding. Travoprost may get into your milk.

Ask your doctor for advice before taking any medicine.

Driving and using machines

You may find that your vision is blurred for a time just after you use Travoprost. Do not drive or use machines until this has worn off.

Travoprost contains benzalkonium chloride

This medicine contains 0.150 mg

benzalkonium chloride in each ml.

Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.

Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.

Travoprost contains macrogol glycerol hydroxy stearate 40, which may cause skin reactions.

3 How to use Travoprost

Always use this medicine exactly as your doctor or the doctor treating your child has told you. Check with your doctor, the doctor treating your child or pharmacist if you are not sure.

One drop in the affected eye or eyes, once a day in the evening.

Only use Travoprost in both eyes if your doctor told you to. Use it for as long as your doctor or the doctor treating your child told you to.

Only use Travoprost for dropping in your or your child’s eyes.

1 • Immediately before

using a bottle for the first time, tear off the overwrap pouch (picture 1). Take out the bottle and write the date of opening on the label in the space provided.

  • Get the medicine bottle and a mirror.
  • Wash your hands.
  • Twist off the cap.

2 • Hold the bottle,

pointing down,

between your thumb and fingers.

  • Tilt your head or your child’s head gently back. Pull down the eyelid with a clean finger, until there is a ‘pocket’ between the eyelid and the eye. The drop will go in here (picture 2).
  • Bring the bottle tip close to the eye. Use the mirror if it helps.

3 • Do not touch the

eye or eyelid, surrounding areas or other surfaces with the dropper.

It could infect the drops.

  • Gently squeeze the bottle to release one drop of medicine at a time (picture 3).
  • After using the

    medicine, keep the eyelid closed, apply gentle pressure by pressing a finger into the corner of the eye, by the nose (picture 4) for at least 1 minute. This helps to stop the medicine getting into the rest of the body.

4 • If you use drops in

both eyes, repeat these same steps for the other eye.

  • Close the bottle cap firmly immediately after use.
  • Only use one bottle of medicine at a time. Do not open the pouch until you need to use the bottle. If a drop misses your eye, try again.

If you or your child are using other eye preparations such as eye drops or eye ointment, wait for at least 5 minutes between putting in Travoprost and the other eye preparations.

If you or your child receive more

Travoprost than you should

Rinse all the medicine out with warm

Package leaflet: Information for the patient Travoprost 40micrograms/ml Eye Drops, Solution

Continued top of next column Continued over page water. Do not put in any more drops until it is time for your next regular dose. If you forget to use Travoprost

Continue with the next dose as planned. Do not use a double dose to make up for a forgotten dose. Never use more than one drop in the affected eye(s) in a single day.

If you stop using Travoprost

Do not stop using this medicine without first speaking to your doctor or the doctor treating your child, the pressure in your eye or your child’s eye will not be controlled which could lead to loss of sight.

If you have any further questions on the use of this medicine, ask your doctor, the doctor treating your child or pharmacist.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You can usually carry on using the drops, unless the side effects are serious. If you are worried, talk to your doctor or pharmacist. Do not stop using Travoprost without speaking to your doctor.

The following side effects have been seen with Travoprost.

Very common side effects: may affect more than 1 in 10 people

Effects in the eye:

  • eye redness.

Common side effects: may affect up to 1 in 10 people

Effects in the eye:

  • changes in the colour of the iris (coloured part of the eye)
  • eye pain, eye discomfort
  • dry eye
  • itchy eye
  • eye irritation.

Uncommon side effects: may affect up to 1 in 100 people

Effects in the eye:

  • corneal disorder
  • eye inflammation
  • iris inflammation
  • inflammation inside the eye
  • eye surface inflammation with/without surface damage
  • sensitivity to light
  • eye discharge
  • eyelid inflammation
  • eyelid redness
  • swelling around the eye
  • eyelid itching
  • blurred vision
  • increased tear production
  • infection or inflammation of the conjunctiva (conjunctivitis)
  • abnormal turning outward of the lower eyelid
  • clouding of the eye
  • eyelid crusting
  • growth of eyelashes.

General side effects:

  • increased allergic symptoms
  • headache
  • irregular heartbeat
  • cough
  • stuffy nose
  • throat irritation
  • darkening of skin around the eye(s)
  • skin darkening
  • abnormal hair texture
  • excessive hair growth.

Rare side effects: may affect up to 1 in 1,000 people

Effects in the eye:

  • perception of flashing lights
  • eczema of the eyelids
  • abnormally positioned eyelashes that grow back toward the eye
  • eye swelling
  • reduced vision
  • halo vision
  • decreased eye sensation
  • inflammation of the glands of the eyelids
  • pigmentation inside the eye
  • increase in pupil size
  • eyelash thickening
  • change in eyelash colour
  • tired eyes.

General side effects:

  • eye viral infection
  • dizziness
  • bad taste
  • irregular or decreased heart rate
  • increased or decreased blood pressure
  • shortness of breath
  • asthma
  • nasal allergy or inflammation
  • nasal dryness
  • voice changes
  • gastrointestinal discomfort or ulcer
  • constipation
  • dry mouth
  • redness or itching of the skin
  • rash
  • hair colour change
  • loss of eyelashes
  • joint pain
  • musculoskeletal pain
  • generalised weakness.

    Not known: frequency cannot be estimated from the available data

    Effects in the eye:

    • inflammation of the back of the eye, eyes appear more inset.

General side effects:

  • depression
  • anxiety
  • insomnia
  • sensation of false movement
  • ringing in ears
  • chest pain
  • abnormal heart rhythm
  • increased heart beat
  • worsening of asthma
  • diarrhoea
  • nose bleeds
  • abdominal pain
  • nausea
  • vomiting
  • itching
  • abnormal hair growth
  • painful or involuntary urination
  • increase in prostate cancer marker.

In children and adolescents, the most common side effects seen with Travoprost are eye redness and growth of eyelashes. Both side effects were observed with a higher incidence in children and adolescents compared to adults.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Travoprost

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle and the box after ‘Exp’. The expiry date refers to the last day of the month.

Do not use this medicine if you notice that the tamper evident seal has been broken or damaged before you first open it.

Before opening, keep bottle in overwrap pouch in order to protect from moisture. After first opening this medicine does not require any special storage conditions. You must throw away the bottle 4 weeks after you first opened it, to prevent infections, and use a new bottle. Write down the date you opened the bottle in the space on each bottle label and box.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other information

What Travoprost contains

  • The active substance is travoprost. Each ml of solution contains 40micrograms of travoprost.
  • The other ingredients are benzalkonium chloride solution, macrogol glycerol hydroxy stearate 40, trometamol, disodium edetate, boric acid (E284), mannitol (E421), sodium hydroxide for pH adjustment and purified water.

What Travoprost looks like and the contents of the pack

Travoprost Eye Drops, Solution is a clear, colourless solution supplied in packs containing translucent polypropylene 5ml bottle(s) with transparent low density polyethylene (LDPE) dropper and white high density polyethylene (HPDE) tamper-proof screw cap packaged in overwrap pouch. Each bottle contains 2.5ml solution.

The product is available in the following pack sizes:

Cartons containing 1 or 3 bottles.

Marketing Authorisation Holder

Accord, Barnstaple, EX32 8NS, UK Manufacturer

Pharmathen S.A.

6 Dervenakion str.

15351 Pallini

Attiki

Greece

Balkanpharma-Razgrad AD

68 Aprilsko vastanie Blvd.

Razgrad

7200

Bulgaria

JADRAN - GALENSKI LABORATORIJ d.d. Svilno 20, Rijeka 51000, Croatia

This leaflet was last revised in May 2023.

BBBB7070

Continued top of next column

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00142/1061

Last revision stated in the text: May 2023 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Travoprost 40 micrograms / ml eye drops solution

What these facts mean

Active substance? Travoprost
Strength? 40 micrograms / ml
Pharmaceutical form? Eye drops
Clear, colourless solution.
pH: 5.5-7.0
Osmolality: 266-294 mOsm/Kg
How is it taken? Ocular
Excipients? Benzalkonium chloride solution, Macrogol glycerol hydroxy stearate 40, Trometamol, Disodium edetate, Boric acid (E284), Mannitol (E421), Sodium hydroxide (for pH-adjustment), Purified water
Is it available?? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? Unopened product: 3 years
Discard 4 weeks after first opening.
Storage Before opening, keep bottle in overwrap pouch in order to protect from moisture.
After first opening, this medicinal product does not require any special storage conditions.
Drug group (ATC)? Ophthalmologicals – antiglaucoma preparations and miotics – prostaglandin analogues
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01E Antiglaucoma preparations and miotics
        1. S01EE Prostaglandin analogues, antiglaucoma drugs and miotics
          1. S01EE04 travoprost
Marketing authorisation? PL 00142/1061 (first authorised 1 October 2014)
Marketing authorisation holder? Accord-UK Ltd
Codes? BNF 11060000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.2.0 of 16 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.